BCWORLD PHARM. Co. Ltd (200780) — Cash Flow-to-Debt Ratio
BCWORLD PHARM. Co. Ltd (200780) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩1.43 Billion could theoretically repay 0% of its total liabilities (₩101.30 Billion) in one year. See BCWORLD PHARM. Co. Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
BCWORLD PHARM. Co. Ltd Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for BCWORLD PHARM. Co. Ltd across 10 annual periods. Also explore 200780 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year debt coverage analysis for BCWORLD PHARM. Co. Ltd. For market capitalisation and broader financial context, see market cap of BCWORLD PHARM. Co. Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.04x | ₩4.04 Billion | ₩99.65 Billion | ▼ -62.0% |
| 2023 | 0.11x | ₩10.94 Billion | ₩102.47 Billion | ▲ +60.5% |
| 2022 | 0.07x | ₩6.88 Billion | ₩103.50 Billion | ▲ +1150.4% |
| 2021 | -0.01x | ₩-619.83 Million | ₩97.90 Billion | ▲ +89.5% |
| 2020 | -0.06x | ₩-5.50 Billion | ₩91.27 Billion | ▼ -137.6% |
| 2019 | 0.16x | ₩12.11 Billion | ₩75.53 Billion | ▲ +115.1% |
| 2018 | 0.07x | ₩5.34 Billion | ₩71.65 Billion | ▼ -65.0% |
| 2017 | 0.21x | ₩7.90 Billion | ₩37.11 Billion | ▲ +1869.4% |
| 2016 | 0.01x | ₩243.66 Million | ₩22.54 Billion | ▼ -98.5% |
| 2015 | 0.73x | ₩8.78 Billion | ₩11.96 Billion | — |